We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+13.14%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.69B
AUM Growth
+$474M
Cap. Flow
+$80.4M
Cap. Flow %
1.71%
Top 10 Hldgs %
8.06%
Holding
1,297
New
117
Increased
489
Reduced
309
Closed
101

Top Buys

Rank Stock Value
1
GT icon
Goodyear
GT
+$19.2M
2
ATKR icon
Atkore
ATKR
+$16.5M
3
TRN icon
Trinity Industries
TRN
+$15.4M
4
OI icon
O-I Glass
OI
+$15M
5
VSXY
Victoria's Secret
VSXY
+$14.6M

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$25.2M
2
SKYW icon
Skywest
SKYW
+$15.4M
3
TTMI icon
TTM Technologies
TTMI
+$14.9M
4
PARR icon
Par Pacific Holdings
PARR
+$13M
5
SCS
Steelcase
SCS
+$11.8M

Sector Composition

Rank Sector Weight
1 Financials 27.39%
2 Consumer Discretionary 13.71%
3 Technology 12.21%
4 Industrials 11.36%
5 Energy 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGLD icon
1126
Marygold Companies
MGLD
$46.1M
$85.4K ﹤0.01%
79,767
LTRX icon
1127
Lantronix
LTRX
$266M
$85K ﹤0.01%
+18,600
New +$68.8K
LOAN
1128
Manhattan Bridge Capital
LOAN
$47.1M
$84K ﹤0.01%
15,216
LSF icon
1129
Laird Superfood
LSF
$47.8M
$83.7K ﹤0.01%
15,000
AWX icon
1130
Avalon Holdings
AWX
$10.1M
$82.2K ﹤0.01%
31,528
CULP icon
1131
Culp Inc
CULP
$44.1M
$81.6K ﹤0.01%
18,300
XPL icon
1132
Solitario Resources
XPL
$71.7M
$79.9K ﹤0.01%
114,500
-40,500
-26% -$29.3K
PRLD icon
1133
Prelude Therapeutics
PRLD
$390M
$77K ﹤0.01%
53,500
-35,000
-40% -$35.1K
ANTX icon
1134
AN2 Therapeutics
ANTX
$214M
$76.1K ﹤0.01%
59,900
GCTS
1135
GCT Semiconductor Holding
GCTS
$235M
$76K ﹤0.01%
+50,000
New +$71.3K
CAMP icon
1136
CAMP4 Therapeutics
CAMP
$266M
$75K ﹤0.01%
25,000
RVP icon
1137
Retractable Technologies
RVP
$20.1M
$74.6K ﹤0.01%
88,543
-67,087
-43% -$51.2K
FARM
1138
DELISTED
Farmer Brothers
FARM
$73.4K ﹤0.01%
42,900
GUTS icon
1139
Fractyl Health
GUTS
$111M
$72.3K ﹤0.01%
45,500
INUV icon
1140
Inuvo
INUV
$17M
$70.2K ﹤0.01%
20,000
PRPL icon
1141
Purple Innovation
PRPL
$41.7M
$70.1K ﹤0.01%
+3,000
New +$70.1K
IRD
1142
Opus Genetics
IRD
$302M
$69.4K ﹤0.01%
42,065
NOTE
1143
DELISTED
FiscalNote
NOTE
$69K ﹤0.01%
14,907
+12,999
+681% +$84K
RBOT
1144
DELISTED
Vicarious Surgical
RBOT
$68.6K ﹤0.01%
12,444
+644
+5% +$4.92K
AIRI icon
1145
Air Industries Group
AIRI
$12.8M
$66.2K ﹤0.01%
21,151
ALXO icon
1146
ALX Oncology
ALXO
$283M
$65.9K ﹤0.01%
+36,000
New +$31.2K
LITS
1147
Lite Strategy Inc
LITS
$30.9M
$65K ﹤0.01%
26,869
TVGN icon
1148
Tevogen Inc. Common Stock
TVGN
$27.3M
$64.8K ﹤0.01%
1,650
+660
+67% +$32.5K
CVU icon
1149
CPI Aerostructures
CVU
$68.5M
$64.3K ﹤0.01%
25,500
ATNM icon
1150
Actinium Pharmaceuticals
ATNM
$25M
$64K ﹤0.01%
40,000

Similar funds

Bridgeway Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Bridgeway Capital Management held 1,297 positions worth $4.69B, up 11% from $4.21B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Bridgeway Capital Management's Q3 2025 filing shows 117 new, 489 increased, 309 reduced and 101 closed positions. Its largest new stake was Goodyear: 2,042,732 shares worth $15.3M. The largest sale was TEGNA Inc, an estimated $25.2M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q3 2025 buy was Goodyear: 2,042,732 shares worth $15.3M.
  • Bridgeway Capital Management added most to Sylvamo in Q3 2025, an estimated $9.75M increase.
  • Bridgeway Capital Management's biggest Q3 2025 reduction was TEGNA Inc, cutting an estimated $25.2M.
  • Bridgeway Capital Management fully exited Par Pacific Holdings in Q3 2025, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 8.1% of its $4.69B portfolio in Q3 2025.
  • Bridgeway Capital Management opened 117 new positions and closed 101 in Q3 2025.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.69B.

Based on Bridgeway Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.